RADİKAL JİNEKOLOJİK CERRAHİNİN
ÜRİNER İNKONTİNANS’ A ETKİSİ
Amaç: Çalışmanın amacı jinekolojik kanser tedavisinin üriner inkontinans semptomlarına olan etkisinin araştırılmasıdır. Metot: Çalışma endometrium ve over kanseri tanısıyla lenf nodu diseksiyonu geçirmiş 76 hastayı kapsamaktadır. Tedavi öncesi dönemde ürojinekolojik muayene , “ Kadınlarda Üriner İnkontinans Skoru”, Incontinence Impact Questionnaire-7 (IIQ7), Urogenital Distress Inventory-6 (UDI6) anket formları doldurulmuş ve tedavi sonrası 6. Haftada tekrarlanmıştır. Sonuçlar: Katılımcıların ortalama yaşları 57,7±10,5 ve ortalama pariteleri 2,6±1,2 dır. Toplam 44 (%57) hastada muayene ve “Kadınlarda Üriner İnkontinans Skoru” testiyle stres inkontinans, urge inkontinans veya miks inkontinans saptandı. Tedavi öncesinde stres üriner inkontinans, urge inkontinans ve miks inkontinans oranları sırasıyla %52,3, %9 ve %38,7’dir. Yirmi dört (%31) hasta over kanseri tanısıyla ve 52 (%69) hasta endometrium kanseri tanısıyla opere edilmiştir. Operasyonlar sırasında üriner sistem zedelenmesi olmamıştır. Operasyon sonrası 6. haftada üriner inkontinans oranı %71’dir ve fark istatistiksel olarak anlamlıdır (p<,05). Operasyon öncesi ve sonrası IIQ7 ve UDI6 skorları arasında istatistiksel olarak anlamlı artış vardı (p<,05). Anket formları kendi içlerinde değerlendirildiğinde IIQ7 test sonuçlarında fiziksel aktivite ve seyahat skorlarında anlamlı farklılıklar saptandı. Sonuç: Radikal jinekolojik operasyonların üriner inkontinans semptomları üzerinde ciddi olumsuz etkileri vardır. Üriner semptomların hayat kalitesinde olumsuz etkileri vardır. Önleyici yaklaşımlar jinekolojik cerrahi sonrası tüm hastalara önerilmelidir.
THE EFFECT OF RADİCAL
GYNECOLOGİC SURGERY ON URİNARY
İNCONTİNENCE
Objectives: The aim of the study was evaluate the effect of gynecologic cancer treatment on urinary incontinence symptoms. Methods: This study includes 76 patients who underwent lymhnode disection surgery for endometrial cancer and ovarian cancer. At preoperative period urogynecologic examination and “Urinary incontinence score for females” test were performed. Preoperative IIQ-7 (Incontinence Impact Questionnaire-7), UDI-6 (Urogenital Distress Inventory-6) and were performed before treatment and at the 6th week after surgery for all patients. Results: The mean age and parity of patients were 57,7 ±10,5 and 2,6 ± 1,2. Total of 44 patients (57%) who were diagnosed stress or urge incontinence by examination or “Urinary incontinence score for females” test. The percentage of stress urinary incontinence and urge incontinence were 52, 3% and 9%. The percentage of mixed incontinence was 38,7%. Twenty four (31%) of 76 procedures were performed for ovarian cancer and 52 (69%) procedures were performed for endometrial cancer. There was no urinary track injury during procedures. The percentage of urinary incontinence at 6th week after surgery was 71% and difference was significant (p<.05).The difference between preoperative IIQ- 7 and UDI-6 score and postoperative IIQ- 7 and UDİ- 6 scores were significantly different (p<.05). When compare the items of IIQ- 7 test, physical activity and travel items were significantly difference. Conclusions: Radical gynecologic surgery has serious adverse effect on urinary incontinence symptoms. Urinary symptoms could impair quality of life after surgery. Preventive approaches should suggest patient early after operation.
___
- 1. T.C. Sağlık Bakanlığı. Türkiye’de Bölgelere ve Cinsiyete
Göre Kanser Olguları, 2002 yılı verileri, www.saglik.gov.tr
2. T.C. Sağlık Bakanlığı. Türkiye Kanser İstatislikleri. M. Gültekin,
G. Boztaş. Ocak 2014.
- 3. Carter J, Penson R, Barakat R, Wenzel L. Contemporary
quality of life issues affecting gynecologic cancer survivors.
HematolOncolClin North Am. 2012 Feb;26(1):169-94.
- 4. Abrams P, Cardozo L, Fall M, Griffiths D, RosierP,Ulmsten
U. The standardization of terminology of lowe rurinary tract
function: report from the standardization sub-committee
of the International Continence Society. NeurourolUrodyn
2002; 21: 167 -178.
- 5. Kinchen KS, Burgio K, Diokno AC, Fultz NH, Bump R,
Obenchain R. Factors associated with women’s decisions to
seek treatment for urinary in continence. J Womens Health
2003; 12: 687-698
- 6. Hagglund D, Walker-Engstrom M-L, Larsson G, Leppert J.
Reasons why women with long-term urinary incontinence
do not seek Professional help: a cross-sectional populationbased
cohort study. IntUrogynecol J 2003; 14: 296-304.
- 7. Herzog RA, Fultz NH, Normolle DP, et al. Methods used to
manage of urinary incontinence in the elderly. Journal of
theAmericanGeriatricsociety 37: 339-347, 1989.
- 8. Cam Ç, Sakalli M, Ay P,Cam M, Karateke A. Validation of
the Short Forms of the Incontinence Impact Questionnaire
(IIQ-7) and the UrogenitalDistress Inventory (UDI6)
in a Turkish Population. NeurourologyandUrodynamics26:129-133
(2007)
- 9. Wyman JF, Harkins SW, Choi SC, Taylor JR, Fantl JA. Psychosocia
limpact of urinary incontinence in women. ObstetGynecol.
1987 Sep; 70(3 Pt 1): 378- 81.
- 10. Uebersax, J.S.,Wyman, J. F., Shumaker, S. A., McClish, D. K.,
Fantl, J. A., & the
Continence Program for Women Research Group. (1995). Short
forms to assess life quality and symptom distress for urinary
incontinence in women: The incontinence impact questionnaire
and the urogenital distress inventory. NeurourologyandUrodynamics,
14, 131-139.
- 11. Gaudenz R. [A questionnaire with a new urge-scoreand
stresss core for the evaluation of female urinary incontinence
(author’stransl)] Geburt shilfe Frauenheilkd. 1979
Sep; 39(9): 784- 92. German
- 12. Ishiko O, Sumi T, Hirai K, Ogita S. Classification of female
urinary incontinence by the scored incontinence questionnaire.
Int J GynaecolObstet. 2000 Jun; 69(3): 255- 60.
- 13. Maral I, Özkardeş H, PeskircioğluL,Bumin MA. Prevalence
of stres urinary incontinence in both sexes at or after age 15
years: a cross-sectional study. J Urol 2001; 165:408-412
- 14. Filiz TM, Uludağ C, Çınar N, Gorpelioğlu S, Topsever P. Risk
factors for urinary
incontinence in Turkish women. SaudiMed J 2006; 27(11):1688-
1692.
- 15. Buchsbaum GM, Chin M, Glantz C, Guzick D. Prevalence of
urinary incontinence and associated risk factors in a cohort
of nuns. ObstetGynecol 2002; 100:226-9
- 16. Simeonova Z, Milsom I, Kullendorff AM, Molander U,
Bengtsson C. The prevalence of urinary incontinence and
its influence on the quality of life in women from an urban Swedish population. Acta Obstet GynecolScand 1999;
78:546-51.
- 17. Johnson 2nd TM, Kincade JE, Bernard SL, Busby-Whitehead
J, Hertz-Picciotto I, DeFriese GH. The association of
urinary incontinence with poor self-rated health. JAmGeriatrSoc
1998;46(6):693–9.
- 18. Sensoy N, Dogan N, Ozek B, Karaaslan L. Urinary incontinence
in women: prevalence rates, risk factors and impact
on quality of life. Pak J Med Sci. 2013 May;29(3):818-22.
- 19. Lasserre, A., Pelat, C., Guéroult, V., Hanslik, T., ChartierKastler,
E., Blanchon, T., ... & Bloch, J. (2009). Urinary incontinence
in French women: prevalence, risk factors, and
impact on quality of life. European urology, 56(1), 177-183.
- 20. Erekson EA, Sung VW, DiSilvestro PA, Myers DL. Urinary
symptoms and impact on quality of life in women after
treatment for endometrial cancer. IntUrogynecol J PelvicFloorDysfunct
2009;20(2):159–63.
- 21. Herwig R, Bruns F, Strasser H, et al. Late urologic effects
after adjuvant irradiation in stage I endometrial carcinoma.
Urology. 2004 Feb;63(2):354-8.
- 22. Nout RA, Putter H, Jü rgenliemk-Schulz IM, et al. Quality
of life after pelvic radiotherapy or vaginal brachytherapy for
endometrial cancer: first results of the randomized PORTEC-2
trial. J Clin Oncol. 2009 Jul 20;27(21):3547-56.
- 23. Nout RA, van de Poll-Franse LV, Lybeert ML, et al. Longterm
outcome and quality of life of patients with endometrial
carcinoma treated with or without pelvic radiotherapy
in the post operative radiation therapy in endometrial
carcinoma 1 (PORTEC-1) trial. J Clin Oncol. 2011 May
1;29(13):1692-700.
- 24. Rutledge T, Rogers R, Lee SJ, Muller CY. A pilot randomized
control trial to evaluate pelvic floor muscle training for urinary
incontinence among gynecologic cancer survivors. Gynecologic
Oncology 132 (2014) 154–158.